International travel: Recommendations for the HIV-infected patient

Lisa A. Spacek, Thomas C. Quinn

Research output: Contribution to journalReview articlepeer-review

Abstract

In order to prevent travel-related diseases in patients infected with HIV, pretravel planning that includes vaccination, chemoprophylaxis, and behavioral modification is recommended. Many HIV-infected individuals successfully treated with highly active antiretroviral therapy may travel safely. However, patients with reduced CD4 lymphocyte counts are at increased risk for bacterial, mycobacterial, viral, fungal, and parasitic infections. Recommendations for vaccination and chemoprophylaxis are based on immune status and risk of infection. The efficacy of vaccination is dependant on CD4 lymphocyte count; inactivated and polysaccharide vaccines are considered safe in this population. Behavioral modifications to prevent food- and water-borne disease are an important component of disease prevention. A travel-health practitioner should review travel duration, destination, and activities, and assess the risk-benefit ratio of vaccination and chemoprophylaxis, in order to reduce the likelihood of travel-associated illnes.

Original languageEnglish (US)
Pages (from-to)399-403
Number of pages5
JournalCurrent Infectious Disease Reports
Volume6
Issue number5
DOIs
StatePublished - Oct 2004
Externally publishedYes

ASJC Scopus subject areas

  • Infectious Diseases

Fingerprint Dive into the research topics of 'International travel: Recommendations for the HIV-infected patient'. Together they form a unique fingerprint.

Cite this